Regeneron Pharmaceuticals, Inc. (REGN) at a glance
Regeneron Pharmaceuticals, Inc. (REGN) is a large-cap Healthcare company. It trades at $784.14, with a P/E of 14.9, a 29.6% profit margin and revenue growth of 19%. It pays a 0.6% dividend yield. Vestovix scores it 67/100 overall. Its strongest dimension is Safety (94/100) and its weakest is Income (35/100). It is a relatively defensive holding with below-market volatility.
- Price
- $784.14
- Market cap
- $64.18B
- P/E ratio
- 14.9
- Dividend yield
- 0.60%
- Beta
- 0.24
- 52-week range
- $541.00 to $847.00
Value
90
Growth
46
Income
35
Safety
94
Momentum
72
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield